Abstract
No public abstract is available from the verified source records.
Filippo Crea
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acids
10.1093/eurheartj/ehaf520 · 2026
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial
10.1093/eurheartj/ehaf685 · 2026
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome
10.1093/eurheartj/ehaf660 · 2026
Gene therapy and genome editing for lipoprotein disorders
10.1093/eurheartj/ehaf411 · 2025
SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias
10.1093/eurheartj/ehaf053 · 2025
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome
10.1093/eurheartj/ehae476 · 2024
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers
10.1093/eurheartj/ehae409 · 2024
Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC)
10.1093/eurheartj/ehag353 · 2026
Myocardial bridging: a practical guide for clinicians
10.1093/eurheartj/ehaf1038 · 2026
Coronary autoregulation: the complex interplay between epicardial and microvascular resistance
10.1093/eurheartj/ehag145 · 2026
Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques
10.1093/eurheartj/ehag103 · 2026
Carotid artery atherosclerosis: mechanisms of instability and clinical implications
10.1093/eurheartj/ehae933 · 2025
Mediterranean diet, neutrophil count, and carotid intima-media thickness in secondary prevention: the CORDIOPREV study
10.1093/eurheartj/ehae836 · 2025
Cortico-limbic interactions and carotid atherosclerotic burden during chronic stress exposure
10.1093/eurheartj/ehae149 · 2024
Carotid artery stenting in asymptomatic disease: a new paradigm
10.1093/eurheartj/ehag195 · 2026
Angiography-derived fractional flow reserve- vs usual care-guided percutaneous coronary intervention: interim analysis of the PIONEER IV trial
10.1093/eurheartj/ehag174 · 2026
Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis
10.1093/eurheartj/ehaf962 · 2026
Heart rate-lowering drugs and outcomes in hypertension and/or cardiovascular disease: a meta-analysis
10.1093/eurheartj/ehaf291 · 2025
Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease
10.1093/eurheartj/ehaf225 · 2025
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
10.1093/eurheartj/ehae178 · 2024
Preeclampsia, gestational hypertension, and cardiovascular disease risk: a genetic epidemiological study
10.1093/eurheartj/ehaf565 · 2025
Combined hepatorenal denervation for hypertension and cardiometabolic disease: a first-in-human study
10.1093/eurheartj/ehag460 · 2026
Routine FFR-guided revascularization in patients undergoing transcatheter aortic valve implantation, one step too far?
10.1093/eurheartj/ehag256 · 2026
Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial
10.1093/eurheartj/ehaf974 · 2026
FFR-guided revascularization in patients undergoing TAVI: insights on the FAITAVI trial
10.1093/eurheartj/ehag259 · 2026
No additional external references are available.